Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Nivolumab and Metformin in Patients With Treatment Refractory MSS Metastatic Colorectal Cancer

NCT03800602 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03800602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03800602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Nivolumab and Metformin in Patients With Treatment Refractory MSS Metastatic Colorectal Cancer
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2019
Completion date
September 4, 2021
Enrollment
29 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma, colorectal cancer metastatic, metastatic microsatellite stable colorectal carcinoma, refractory colorectal carcinoma, stage iv colorectal cancer, stage iva colorectal cancer, stage ivb colorectal cancer, stage ivc colorectal cancer